Description
RETATRUTIDE 20MG
20mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Retatrutide is an experimental peptide within the incretin class, acting as a triple agonist of the GLP-1, GIP, and GCGR receptors. This high-concentration 20mg format is designed for extended experimental protocols studying synergistic impacts on metabolic pathways and energy expenditure.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Retatrutide 20mg |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-diacid-C20-γ-Glu-(AEEA)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731.33 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 20 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
Retatrutide 20mg Research Application Areas
Current laboratory studies on Retatrutide 20mg focus on the following key research areas:
- Triple Hormonal Agonism: Simultaneous activation of GLP-1, GIP, and Glucagon receptors.
- Enhanced Lipid Oxidation: Study of lipolysis and hepatic steatosis reduction in biological models.
- Energy Metabolism: Impact of the glucagon receptor on basal metabolic rate elevation.
- Comparative Dosage Studies: Research on the efficacy of the 20mg concentration in satiety mechanisms.
Looking for another Retatrutide 20mg alternative? Explore our full range of Research Peptides.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
